Taro Pharmaceutical Industries Ltd (NYSE:TARO)

100.73
Delayed Data
As of Apr 19
 -0.76 / -0.75%
Today’s Change
93.01
Today|||52-Week Range
128.46
-3.80%
Year-to-Date
No recent news for Taro Pharmaceutical Industries Ltd.

Today’s Trading

Previous close101.49
Today’s open101.50
Day’s range100.62 - 102.13
Volume33,228
Average volume (3 months)89,451
Market cap$4.0B
Data as of 4:01pm ET, 04/19/2018

Growth & Valuation

Earnings growth (last year)-12.51%
Earnings growth (this year)-14.10%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-7.51%
P/E ratio19.5
Price/Sales5.48
Price/Book1.96

Competitors

 Today’s
change
Today’s
% change
ACADACADIA Pharmaceutica...-0.32-1.60%
AKRXAkorn Inc+0.05+0.26%
----
MNKMallinckrodt Plc+0.05+0.36%
Data as of 4:00pm ET, 04/19/2018

Financials

Next reporting dateMay 24, 2018
EPS forecast (this quarter)--
Annual revenue (last year)$879.4M
Annual profit (last year)$456.4M
Net profit margin51.93%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Director
Uday Vijaykumar Baldota
Vice President &
Operations Head-Haifa
Itamar Karsenti
Corporate headquarters
Haifa Bay, Haifa

Forecasts